entertainment -WSS

entertainment

author：comprehensive 2025-10-01 17:06:54 - browse：2899

The ability of cancer cells to move and spread depends on actin-rich core structures such as the podosomes (yellow) shown here in melanoma cells. Cell nuclei (blue), actin (red), and an actin regulator (green) are also shown. — Metastatic melanoma cells Julio C. Valencia,/NCI Center for Cancer Research

Nearly four decades after its first conception, the first TIL therapy, an immunotherapy that harvests cancer-fighting immune cells from the patient’s own body, received accelerated approval from the Food and Drug Administration for advanced melanoma. The therapy, called Amtagvi or lifileucel from Iovance, is the first cell therapy approved for a solid tumor.

“It’s so exciting and gratifying,” said Allison Betof Warner, a cell therapy researcher and physician at Stanford University who has worked on Amtagvi. “This is a game-changing moment for our field. We’ve seen huge success of cellular therapy for hematologic malignancies, and we’ve yet to capitalize on that for solid tumors. This is hopefully the first of many to come.”

In a Phase 2 clinical trial, titled C-144-01, 153 patients who had already been on a median of three prior lines of therapy received lifileucel, and 31% of them responded to therapy. “These are in very late line patients. They’ve exhausted every standard care option,” Betof Warner said. “The most promising part of this therapy for me is that 42% of patients who responded were still responding for 18 months or longer. It’s truly incredible.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Why you get paid to donate plasma but not blood

focus

WSS

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

What the Wegovy shortage looks like for doctors — and for patients

Life sciences deals on track to hit lowest point since 2017

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Lack of darker skin in textbooks, journals harms patients of color

Medicare to cover more brain scans related to Alzheimer’s drugs

hotspot

entertainment

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

How doctors and nurses shape Google's AI

Tori Bowie and the unacceptable rates of Black maternal death

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

House passes resolution saying Israel isn't a 'racist or apartheid state'

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A look at other Americans who have crossed into North Korea over the years

FDA approval of Sarepta Duchenne genetic therapy gives me hope

European regulators consider appeal over Amylyx ALS drug

hotspot

Peter Marks talks Operation Warp Speed for Rare Diseases

STAT Readout Newsletter: Today in biotech, life science news

Johnson & Johnson sues to stop Medicare negotiation

BridgeBio heart drug succeeds in pivotal study

Massive project maps cells in human brain in unprecedented detail

STAT Readout Newsletter: Today in biotech, life science news

focus

focus

focus

hotspot